Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D
Department of Oncology/Pathology, Karolinska Hospital and Institute, Stockholm, Sweden.
Oncogene. 1999 May 6;18(18):2798-810. doi: 10.1038/sj.onc.1202609.
One prominent effect of IFNs is their cell growth-inhibitory activity. The mechanism behind this inhibition of proliferation is still not fully understood. In this study, the effect of IFN-alpha treatment on cell cycle progression has been analysed in three lymphoid cell lines, Daudi, U-266 and H9. Examination of the growth-arrested cell populations shows that Daudi cells accumulate in a G0-like state, whereas U-266 cells arrest later in G1. H9 cells are completely resistant to IFN-alpha's cell growth-inhibitory effects. The G0/G1-phase arrest is preceded by a rapid induction of the cyclin-dependent kinase inhibitors (CKIs), p21 and p15. In parallel, the activities of the G1 Cdks are significantly reduced. In addition to p21/p15 induction, IFN-alpha regulates the expression of another CKI, p27, presumably by a post-transcriptional mechanism. In the G1 Cdk-complexes, there is first an increased binding of p21 and p15 to their respective kinases. At longer exposure times, when Cdk-bound p15 and p21 decline, p27 starts to accumulate. Furthermore, we found that IFN-alpha not only suppresses the phosphorylation of pRb, but also alters the phosphorylation and expression of the other pocket proteins p130 and p107. These data suggest that induction of p21/p15 is involved in the primary IFN-alpha response inhibiting G1 Cdk activity, whereas increased p27 expression is part of a second set of events which keep these Cdks in their inactive form. Moreover, elevated levels of p27 correlated with a dissociation of cyclin E/Cdk2-p130 or p107 complexes to yield cyclin E/Cdk2-p27 complexes. In resistant H9 cells, which possess a homozygous deletion of the p15/p16 genes and lack p21 protein expression, IFN-alpha causes no detectable changes in p27 expression and, furthermore, no effects are observed on either pocket proteins in this cell line. Taken together, these data suggest that the early decline in G1 Cdk activity, subsequent changes in phosphorylation of pocket proteins, and G1/G0 arrest following IFN-alpha treatment, is not primarily due to loss of the G1 kinase components, but result from the inhibitory action of CKIs on these complexes.
干扰素的一个显著作用是其细胞生长抑制活性。这种增殖抑制背后的机制仍未完全了解。在本研究中,已在三种淋巴细胞系Daudi、U - 266和H9中分析了α干扰素处理对细胞周期进程的影响。对生长停滞的细胞群体进行检查发现,Daudi细胞积聚在类似G0的状态,而U - 266细胞在G1期后期停滞。H9细胞对α干扰素的细胞生长抑制作用完全耐药。在G0/G1期停滞之前,细胞周期蛋白依赖性激酶抑制剂(CKIs)p21和p15会迅速被诱导。同时,G1期细胞周期蛋白依赖性激酶(Cdks)的活性显著降低。除了诱导p21/p15外,α干扰素可能通过转录后机制调节另一种CKI p27的表达。在G1期Cdk复合物中,首先p21和p15与其各自激酶的结合增加。在更长的暴露时间下,当与Cdk结合的p15和p21下降时,p27开始积累。此外,我们发现α干扰素不仅抑制pRb的磷酸化,还改变其他口袋蛋白p130和p107的磷酸化和表达。这些数据表明,p21/p15的诱导参与了抑制G1期Cdk活性的主要α干扰素反应,而p27表达的增加是使这些Cdk保持无活性形式的第二组事件的一部分。此外,p27水平的升高与细胞周期蛋白E/Cdk2 - p130或p107复合物的解离相关,从而产生细胞周期蛋白E/Cdk2 - p27复合物。在对α干扰素耐药的H9细胞中,该细胞系的p15/p16基因纯合缺失且缺乏p21蛋白表达,α干扰素不会导致p27表达出现可检测到的变化,此外,对该细胞系中的任何口袋蛋白都没有影响。综上所述,这些数据表明,α干扰素处理后G1期Cdk活性的早期下降、口袋蛋白磷酸化的后续变化以及G1/G0期停滞,并非主要由于G1期激酶成分的缺失,而是CKIs对这些复合物的抑制作用所致。